SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Following the presentations, each poster will be available on Connect’s website under the Presentations and Publications section.

These therapies provide a foundation for symptom control and exacerbation ... shaping the future of COPD care. Currently ...

Common respiratory condition nearly triples the risk of death in adults, new study finds A major study presented today at ...

Bacterial colonisation is an important predictor of exacerbation in AATD-COPD and may require additional targeted therapy, study suggests.

Researchers sought to determine the effect of COPD exacerbation risk for ASCVD hospitalization in patients with ASCVD.

Hannounced positive feedback from its Type C meeting with the U.S. Food and Drug Administration Division of Pulmonology, Allergy, and Critical Care, in the Office of Immunology and Inflammation. “We ...

New studies on respiratory syncytial virus (RSV) in both adults and young children show that infections are linked to a ...

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared ...